FAS-20013

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameFAS-20013
Drug Alias NameATP synthase inhibitor (FASgen)FAS-20013
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP synthase inhibitors
TargetsATP synthase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFASgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFASgen Inc
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A